Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.

This New Jersey bill mandates that all health insurance plans cover the cost of genetic testing for individuals diagnosed with pancreatic cancer. The law applies to hospital service corporations, medical service corporations, health service corporations, and individual policies issued or renewed in the state after the effective date. Under the new rule, insurers must treat these genetic tests the same as any other medical condition, ensuring they are covered without additional restrictions. The legislation defines genetic testing broadly to include tests that analyze DNA, RNA, chromosomes, or proteins to identify mutations that guide treatment and monitoring.